Kaj Blennow (Former)
191 – 200 of 261
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2018
-
Mark
The impact of preanalytical variables on measuring cerebrospinal fluid biomarkers for Alzheimer's disease diagnosis : A review
- Contribution to journal › Scientific review
-
Mark
Sex-specific genetic predictors of Alzheimer’s disease biomarkers
- Contribution to journal › Article
-
Mark
Update on biomarkers for amyloid pathology in Alzheimer's disease
- Contribution to journal › Scientific review
-
Mark
No association of salivary total tau concentration with Alzheimer's disease
- Contribution to journal › Article
-
Mark
Biology/Disease-Driven Initiative on Protein-Aggregation Diseases of the Human Proteome Project : Goals and Progress to Date
- Contribution to journal › Article
-
Mark
Dietary intervention with an Okinawan-based Nordic diet in type 2 diabetes renders decreased interleukin-18 concentrations and increased neurofilament light concentrations in plasma
- Contribution to journal › Article
-
Mark
Association of cerebral amyloid-β Aggregation with cognitive functioning in persons without dementia
- Contribution to journal › Article
-
Mark
Increased midlife triglycerides predict brain β-amyloid and tau pathology 20 years later
- Contribution to journal › Article
- 2017
-
Mark
Cerebrospinal Fluid Stanniocalcin-1 as a Biomarker for Alzheimer's Disease and Other Neurodegenerative Disorders
(2017) In NeuroMolecular Medicine
- Contribution to journal › Article
-
Mark
Genome-wide, high-content siRNA screening identifies the Alzheimer’s genetic risk factor FERMT2 as a major modulator of APP metabolism
- Contribution to journal › Article
